Veteran health-care industry advocate to step down from medical device group Oct. 15. He replaces John Castellani, who retires this year Ubl Stephen Ubl will be the next CEO of the Pharmaceutical and Research Manufacturers of America, succeeding John Castellani at the lobbying powerhouse. Ubl has led AdvaMed, an association for medical device manufacturers, since 2005. PhRMA's board announced Ubl's selection Sept. 25, after reports on the selection began circulating earlier in the week. The news release cited Ubl's track record of working collaboratively with a broad array of health care stakeholders, and with changes in government review processes and Medicare… Read More